annual CFF:
-$17.14B-$43.21B(-165.76%)Summary
- As of today (June 22, 2025), PFE annual cash flow from financing activities is -$17.14 billion, with the most recent change of -$43.21 billion (-165.76%) on December 31, 2024.
- During the last 3 years, PFE annual CFF has fallen by -$7.32 billion (-74.61%).
- PFE annual CFF is now -165.76% below its all-time high of $26.07 billion, reached on December 31, 2023.
Performance
PFE Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$5.23B-$113.00M(-2.21%)Summary
- As of today (June 22, 2025), PFE quarterly cash flow from financing activities is -$5.23 billion, with the most recent change of -$113.00 million (-2.21%) on March 29, 2025.
- Over the past year, PFE quarterly CFF has dropped by -$296.00 million (-6.00%).
- PFE quarterly CFF is now -119.24% below its all-time high of $27.17 billion, reached on June 1, 2023.
Performance
PFE quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$17.44B-$296.00M(-1.73%)Summary
- As of today (June 22, 2025), PFE TTM cash flow from financing activities is -$17.44 billion, with the most recent change of -$296.00 million (-1.73%) on March 29, 2025.
- Over the past year, PFE TTM CFF has dropped by -$41.34 billion (-172.94%).
- PFE TTM CFF is now -166.89% below its all-time high of $26.07 billion, reached on December 31, 2023.
Performance
PFE TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
PFE Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -165.8% | -6.0% | -172.9% |
| 3 y3 years | -74.6% | +20.5% | -28.3% |
| 5 y5 years | -102.0% | -137.6% | -686.1% |
PFE Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -165.8% | at low | -119.2% | +9.3% | -166.9% | at low |
| 5 y | 5-year | -165.8% | at low | -119.2% | +62.1% | -166.9% | +20.6% |
| alltime | all time | -165.8% | +25.8% | -119.2% | +62.1% | -166.9% | +24.5% |
PFE Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$5.23B(+2.2%) | -$17.44B(+1.7%) |
| Dec 2024 | -$17.14B(-165.8%) | -$5.11B(+10.3%) | -$17.14B(+160.3%) |
| Sep 2024 | - | -$4.64B(+88.5%) | -$6.58B(+15.0%) |
| Jun 2024 | - | -$2.46B(-50.1%) | -$5.73B(-124.0%) |
| Mar 2024 | - | -$4.93B(-190.6%) | $23.91B(-8.3%) |
| Dec 2023 | $26.07B(-275.7%) | $5.44B(-244.0%) | $26.07B(+67.0%) |
| Sep 2023 | - | -$3.78B(-113.9%) | $15.61B(+14.5%) |
| Jun 2023 | - | $27.17B(-1080.7%) | $13.63B(-223.6%) |
| Mar 2023 | - | -$2.77B(-44.7%) | -$11.03B(-25.7%) |
| Dec 2022 | -$14.83B(+51.1%) | -$5.01B(-12.9%) | -$14.83B(+12.6%) |
| Sep 2022 | - | -$5.76B(-328.6%) | -$13.17B(+54.8%) |
| Jun 2022 | - | $2.52B(-138.3%) | -$8.51B(-37.4%) |
| Mar 2022 | - | -$6.58B(+96.3%) | -$13.59B(+38.4%) |
| Dec 2021 | -$9.82B(+1.7%) | -$3.35B(+204.4%) | -$9.82B(-51.5%) |
| Sep 2021 | - | -$1.10B(-56.9%) | -$20.25B(-7.8%) |
| Jun 2021 | - | -$2.56B(-8.9%) | -$21.97B(+114.2%) |
| Mar 2021 | - | -$2.81B(-79.6%) | -$10.26B(+6.3%) |
| Dec 2020 | -$9.65B(+13.7%) | -$13.79B(+388.7%) | -$9.65B(-668.3%) |
| Sep 2020 | - | -$2.82B(-130.8%) | $1.70B(-78.2%) |
| Jun 2020 | - | $9.16B(-516.3%) | $7.79B(-451.3%) |
| Mar 2020 | - | -$2.20B(-9.8%) | -$2.22B(-73.9%) |
| Dec 2019 | -$8.48B(-58.5%) | -$2.44B(-174.5%) | -$8.48B(-31.9%) |
| Sep 2019 | - | $3.27B(-484.6%) | -$12.45B(-27.3%) |
| Jun 2019 | - | -$851.00M(-89.9%) | -$17.13B(-5.8%) |
| Mar 2019 | - | -$8.47B(+32.2%) | -$18.19B(-11.0%) |
| Dec 2018 | -$20.44B(+53.1%) | -$6.41B(+355.7%) | -$20.44B(+15.0%) |
| Sep 2018 | - | -$1.41B(-26.3%) | -$17.78B(-1.7%) |
| Jun 2018 | - | -$1.91B(-82.2%) | -$18.08B(-5.6%) |
| Mar 2018 | - | -$10.72B(+186.4%) | -$19.16B(+43.5%) |
| Dec 2017 | -$13.35B(+44.7%) | -$3.74B(+118.8%) | -$13.35B(+12.0%) |
| Sep 2017 | - | -$1.71B(-42.8%) | -$11.92B(+0.4%) |
| Jun 2017 | - | -$2.99B(-39.1%) | -$11.87B(+70.5%) |
| Mar 2017 | - | -$4.91B(+112.1%) | -$6.96B(-24.5%) |
| Dec 2016 | -$9.23B(-11.3%) | -$2.31B(+39.2%) | -$9.23B(+12.4%) |
| Sep 2016 | - | -$1.66B(-186.7%) | -$8.21B(+20.5%) |
| Jun 2016 | - | $1.92B(-126.7%) | -$6.81B(-35.8%) |
| Mar 2016 | - | -$7.17B(+454.2%) | -$10.60B(+1.9%) |
| Dec 2015 | -$10.41B(+2.2%) | -$1.29B(+392.0%) | -$10.41B(-15.0%) |
| Sep 2015 | - | -$263.00M(-86.0%) | -$12.24B(-17.7%) |
| Jun 2015 | - | -$1.87B(-73.1%) | -$14.87B(-1.1%) |
| Mar 2015 | - | -$6.98B(+123.2%) | -$15.03B(+47.6%) |
| Dec 2014 | -$10.19B(-32.0%) | -$3.13B(+8.3%) | -$10.19B(-20.4%) |
| Sep 2014 | - | -$2.89B(+41.5%) | -$12.80B(-17.6%) |
| Jun 2014 | - | -$2.04B(-4.4%) | -$15.55B(-11.4%) |
| Mar 2014 | - | -$2.13B(-62.9%) | -$17.54B(+17.1%) |
| Dec 2013 | -$14.97B(-6.4%) | -$5.74B(+2.0%) | -$14.97B(-3.2%) |
| Sep 2013 | - | -$5.63B(+39.6%) | -$15.46B(+17.8%) |
| Jun 2013 | - | -$4.03B(-1029.5%) | -$13.12B(+8.8%) |
| Mar 2013 | - | $434.00M(-107.0%) | -$12.06B(-24.6%) |
| Dec 2012 | -$16.00B(-22.4%) | -$6.23B(+89.4%) | -$16.00B(-0.1%) |
| Sep 2012 | - | -$3.29B(+10.9%) | -$16.02B(-4.4%) |
| Jun 2012 | - | -$2.97B(-15.4%) | -$16.76B(-5.4%) |
| Mar 2012 | - | -$3.51B(-43.9%) | -$17.71B(-14.1%) |
| Dec 2011 | -$20.61B(+84.4%) | -$6.25B(+54.9%) | -$20.61B(+33.5%) |
| Sep 2011 | - | -$4.04B(+3.0%) | -$15.44B(+10.9%) |
| Jun 2011 | - | -$3.92B(-38.8%) | -$13.92B(-3.1%) |
| Mar 2011 | - | -$6.40B(+493.5%) | -$14.37B(+28.6%) |
| Dec 2010 | -$11.17B(-177.2%) | -$1.08B(-57.2%) | -$11.17B(-12.9%) |
| Sep 2010 | - | -$2.52B(-42.1%) | -$12.83B(+5.7%) |
| Jun 2010 | - | -$4.36B(+35.8%) | -$12.13B(-842.1%) |
| Mar 2010 | - | -$3.21B(+17.4%) | $1.64B(-88.7%) |
| Dec 2009 | $14.48B(-320.7%) | -$2.73B(+49.6%) | $14.48B(-3.2%) |
| Sep 2009 | - | -$1.83B(-119.4%) | $14.96B(+3.8%) |
| Jun 2009 | - | $9.41B(-2.4%) | $14.41B(+547.1%) |
| Mar 2009 | - | $9.63B(-527.7%) | $2.23B(-133.9%) |
| Dec 2008 | -$6.56B(-48.0%) | -$2.25B(-5.3%) | -$6.56B(+45.6%) |
| Sep 2008 | - | -$2.38B(-14.4%) | -$4.51B(-29.4%) |
| Jun 2008 | - | -$2.78B(-427.5%) | -$6.38B(-7.7%) |
| Mar 2008 | - | $848.00M(-524.0%) | -$6.91B(-45.2%) |
| Dec 2007 | -$12.61B | -$200.00M(-95.3%) | -$12.61B(-24.3%) |
| Sep 2007 | - | -$4.25B(+28.5%) | -$16.66B(-4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2007 | - | -$3.31B(-31.7%) | -$17.52B(-8.7%) |
| Mar 2007 | - | -$4.85B(+14.0%) | -$19.18B(-17.0%) |
| Dec 2006 | -$23.10B(+150.5%) | -$4.25B(-16.6%) | -$23.10B(+59.1%) |
| Sep 2006 | - | -$5.10B(+2.5%) | -$14.52B(+28.7%) |
| Jun 2006 | - | -$4.98B(-43.2%) | -$11.28B(-34.3%) |
| Mar 2006 | - | -$8.77B(-302.6%) | -$17.17B(+86.2%) |
| Dec 2005 | -$9.22B(+39.1%) | $4.33B(-332.3%) | -$9.22B(-45.4%) |
| Sep 2005 | - | -$1.86B(-82.9%) | -$16.90B(-11.2%) |
| Jun 2005 | - | -$10.87B(+1228.6%) | -$19.03B(+110.8%) |
| Mar 2005 | - | -$818.00M(-75.6%) | -$9.03B(+36.2%) |
| Dec 2004 | -$6.63B(-60.8%) | -$3.35B(-16.2%) | -$6.63B(-23.5%) |
| Sep 2004 | - | -$4.00B(+360.9%) | -$8.66B(+5.3%) |
| Jun 2004 | - | -$867.00M(-154.8%) | -$8.22B(-45.4%) |
| Mar 2004 | - | $1.58B(-129.4%) | -$15.07B(-10.9%) |
| Dec 2003 | -$16.91B(+238.2%) | -$5.38B(+51.4%) | -$16.91B(+16.1%) |
| Sep 2003 | - | -$3.56B(-53.9%) | -$14.57B(+21.9%) |
| Jun 2003 | - | -$7.72B(+2961.9%) | -$11.95B(+137.3%) |
| Mar 2003 | - | -$252.00M(-91.7%) | -$5.04B(+0.7%) |
| Dec 2002 | -$5.00B(+138.5%) | -$3.04B(+223.7%) | -$5.00B(+54.4%) |
| Sep 2002 | - | -$940.00M(+17.4%) | -$3.24B(+13.7%) |
| Jun 2002 | - | -$801.00M(+272.6%) | -$2.85B(+55.0%) |
| Mar 2002 | - | -$215.00M(-83.2%) | -$1.84B(-12.4%) |
| Dec 2001 | -$2.10B(-43.4%) | -$1.28B(+133.5%) | -$2.10B(-36.8%) |
| Sep 2001 | - | -$549.00M(-362.7%) | -$3.31B(-0.9%) |
| Jun 2001 | - | $209.00M(-144.1%) | -$3.34B(-20.6%) |
| Mar 2001 | - | -$474.00M(-81.0%) | -$4.21B(+13.7%) |
| Dec 2000 | -$3.71B(+127.7%) | -$2.50B(+332.7%) | -$3.71B(+41.9%) |
| Sep 2000 | - | -$578.00M(-12.2%) | -$2.61B(-10.8%) |
| Jun 2000 | - | -$658.00M(-2156.3%) | -$2.93B(+23.7%) |
| Mar 2000 | - | $32.00M(-102.3%) | -$2.37B(+45.4%) |
| Dec 1999 | -$1.63B(-55.3%) | -$1.41B(+57.6%) | -$1.63B(-45.7%) |
| Sep 1999 | - | -$893.00M(+811.2%) | -$3.00B(+9.7%) |
| Jun 1999 | - | -$98.00M(-112.7%) | -$2.73B(-1.7%) |
| Mar 1999 | - | $771.00M(-127.7%) | -$2.78B(-23.6%) |
| Dec 1998 | -$3.64B(+342.4%) | -$2.78B(+341.8%) | -$3.64B(+162.9%) |
| Sep 1998 | - | -$629.00M(+336.8%) | -$1.39B(+3.1%) |
| Jun 1998 | - | -$144.00M(+61.8%) | -$1.34B(+25.4%) |
| Mar 1998 | - | -$89.00M(-83.0%) | -$1.07B(+30.1%) |
| Dec 1997 | -$823.00M(+124.3%) | -$523.00M(-10.9%) | -$823.00M(-30.0%) |
| Sep 1997 | - | -$587.00M(-558.6%) | -$1.18B(+678.1%) |
| Jun 1997 | - | $128.00M(-19.5%) | -$151.00M(+7.9%) |
| Mar 1997 | - | $159.00M(-118.2%) | -$140.00M(-61.9%) |
| Dec 1996 | -$367.00M(-29.3%) | -$875.00M(-300.2%) | -$367.00M(+192.2%) |
| Sep 1996 | - | $437.00M(+214.4%) | -$125.60M(-84.7%) |
| Jun 1996 | - | $139.00M(-304.4%) | -$821.40M(-32.2%) |
| Mar 1996 | - | -$68.00M(-89.3%) | -$1.21B(+133.2%) |
| Dec 1995 | -$519.10M(-938.6%) | -$633.60M(+144.8%) | -$519.10M(-238.4%) |
| Sep 1995 | - | -$258.80M(+3.4%) | $375.00M(-21.9%) |
| Jun 1995 | - | -$250.40M(-140.1%) | $480.10M(-38.0%) |
| Mar 1995 | - | $623.70M(+139.4%) | $773.80M(+1150.1%) |
| Dec 1994 | $61.90M(-104.0%) | $260.50M(-269.5%) | $61.90M(-104.3%) |
| Sep 1994 | - | -$153.70M(-455.0%) | -$1.45B(-2.9%) |
| Jun 1994 | - | $43.30M(-149.1%) | -$1.50B(-12.5%) |
| Mar 1994 | - | -$88.20M(-93.0%) | -$1.71B(+9.2%) |
| Dec 1993 | -$1.57B(+27.6%) | -$1.25B(+535.8%) | -$1.57B(+99.3%) |
| Sep 1993 | - | -$197.30M(+15.2%) | -$786.20M(+42.4%) |
| Jun 1993 | - | -$171.20M(-406.3%) | -$552.20M(-23.6%) |
| Mar 1993 | - | $55.90M(-111.8%) | -$723.10M(-41.1%) |
| Dec 1992 | -$1.23B(+367.6%) | -$473.60M(-1390.5%) | -$1.23B(+99.4%) |
| Sep 1992 | - | $36.70M(-110.7%) | -$616.00M(-9.2%) |
| Jun 1992 | - | -$342.10M(-23.8%) | -$678.40M(+145.8%) |
| Mar 1992 | - | -$449.00M(-424.4%) | -$276.00M(+5.1%) |
| Dec 1991 | -$262.60M(-47.5%) | $138.40M(-638.5%) | -$262.60M(-2.8%) |
| Sep 1991 | - | -$25.70M(-142.6%) | -$270.30M(+26.7%) |
| Jun 1991 | - | $60.30M(-113.8%) | -$213.30M(-25.4%) |
| Mar 1991 | - | -$435.60M(-433.3%) | -$285.90M(-42.8%) |
| Dec 1990 | -$499.90M(-460.2%) | $130.70M(+317.6%) | -$499.90M(-20.7%) |
| Sep 1990 | - | $31.30M(-354.5%) | -$630.60M(-4.7%) |
| Jun 1990 | - | -$12.30M(-98.1%) | -$661.90M(+1.9%) |
| Mar 1990 | - | -$649.60M | -$649.60M |
| Dec 1989 | $138.80M | - | - |
FAQ
- What is Pfizer annual cash flow from financing activities?
- What is the all time high annual CFF for Pfizer?
- What is Pfizer annual CFF year-on-year change?
- What is Pfizer quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Pfizer?
- What is Pfizer quarterly CFF year-on-year change?
- What is Pfizer TTM cash flow from financing activities?
- What is the all time high TTM CFF for Pfizer?
- What is Pfizer TTM CFF year-on-year change?
What is Pfizer annual cash flow from financing activities?
The current annual CFF of PFE is -$17.14B
What is the all time high annual CFF for Pfizer?
Pfizer all-time high annual cash flow from financing activities is $26.07B
What is Pfizer annual CFF year-on-year change?
Over the past year, PFE annual cash flow from financing activities has changed by -$43.21B (-165.76%)
What is Pfizer quarterly cash flow from financing activities?
The current quarterly CFF of PFE is -$5.23B
What is the all time high quarterly CFF for Pfizer?
Pfizer all-time high quarterly cash flow from financing activities is $27.17B
What is Pfizer quarterly CFF year-on-year change?
Over the past year, PFE quarterly cash flow from financing activities has changed by -$296.00M (-6.00%)
What is Pfizer TTM cash flow from financing activities?
The current TTM CFF of PFE is -$17.44B
What is the all time high TTM CFF for Pfizer?
Pfizer all-time high TTM cash flow from financing activities is $26.07B
What is Pfizer TTM CFF year-on-year change?
Over the past year, PFE TTM cash flow from financing activities has changed by -$41.34B (-172.94%)